Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sofosbuvir For The Treatment Of Hepatitis C Genotype 3 Infected Patients In Pakistan.

Journal of Ayub Medical College, Abbottabad : JAMC - 1 Jan 2000

Akhter Tayyab Saeed, Umar Muhammad, Khaar Hammama-Tul-Bushra, Aslam Faiza, Nisar Gul, Naseer Aqsa, Ahmad Sadia, Osama Muhammad

Abstract excerpt

BACKGROUND: This study was conducted to determine the viral responses of patients with chronic infection of Hepatitis C virus treated with sofubuvir. METHODS: This Quasi experimental study was conducted at Centre for Liver and Digestive Diseases, Holy Family Hospital, Rawalpindi from September 2014 to September 2016. 502 patients with HCV genotype 3 including treatment naive, non-responders or relapsers to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Hepacivirus

Share to Hepatitis C, Chronic

Share to Pakistan

Share to Ribavirin

Share to Sofosbuvir

Source

Identifiers

PMID: 28782338

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sofosbuvir For The Treatment Of Hepatitis C Genotype 3 Infected Patients In Pakistan.PMID 28782338Read ↗

Dramatic response of hepatitis C patients chronically infected with hepatitis C virus genotype 3 to sofosbuvir-based therapies in Punjab, Pakistan: A prospective study.Semantic proximity Read ↗

Sofosbuvir plus ribavirin in treatment-naïve patients with chronic hepatitis C virus genotype 1 or 3 infection in India.Semantic proximity Read ↗

Effectiveness and Safety of Sofosbuvir in Treatment-NäiveChildren with Hepatitis C Infection.Semantic proximity Read ↗

End treatment response and sustained viral response in hepatitis C virus genotype 3 among Pakistani population.Semantic proximity Read ↗

Prevalence of Hepatitis C Virus Genotypes in Pakistan: Current Scenario and Review of LiteratureSemantic proximity Read ↗

Virological Response to Conventional Interferon Therapy Combined with Ribavirin against Various HCV Genotypes in Khyber Pakhtunkhwa, Pakistan.Semantic proximity Read ↗

Effectiveness of Sofosbuvir and Ribavirin for Eradicating Hepatitis C Virus in Renal Transplant Recipients in Pakistan: Where Resources Are Scarce.Semantic proximity Read ↗

Results of sofosbuvir-based combination therapy for chronic hepatitis C cohort of Indian patients in real-life clinical practice.Semantic proximity Read ↗

Response to combination therapy of HCV 3a infected Pakistani patients and the role of NS5A protein.Semantic proximity Read ↗

Hepatitis C Virus and Interferon-Free Antiviral Therapeutics Revolution: Implications for Pakistan.Semantic proximity Read ↗

Sustained virological response based on rapid virological response in genotype-3 chronic hepatitis C treated with standard interferon in the Pakistani population.Semantic proximity Read ↗

Identification of NS5B resistance against SOFOSBUVIR in hepatitis C virus genotype 3a, naive and treated patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.